International Lennox-Gastaut Syndrome Awareness Day
<p>In September 1966, neurologists from around the world gathered in Marseille for the second of a series of symposia convened by the French clinician Henri Gastaut, trying to give a name to a particularly severe and stubborn form of childhood epilepsy. Among them was Margaret Lennox-Buchthal, daughter of the American neurologist William G. Lennox, who had described much the same constellation of symptoms in the United States decades earlier. It was she who proposed that the syndrome be named in honour of her father’s work. The condition that emerged from those meetings, Lennox-Gastaut Syndrome, still bears both names, and 1 November is set aside each year as International Lennox-Gastaut Syndrome Awareness Day, a date dedicated to the people who live with it and the families who care for them.</p>
<h2 id="what-the-condition-is">What the condition is</h2><div class="ad-unit ad-in-article" aria-label="Advertisement">
<span class="ad-label">Advertisement</span>
<ins class="adsbygoogle" style="display:block;text-align:center"
data-ad-client="ca-pub-3726833845844946"
data-ad-slot="3291553914"
data-ad-format="auto"
data-full-width-responsive="true"></ins>
<script>(adsbygoogle = window.adsbygoogle || []).push({});</script>
</div>
<p>Lennox-Gastaut Syndrome, usually shortened to LGS, is a rare and serious epileptic encephalopathy that typically begins between the ages of three and five. What sets it apart from many other forms of epilepsy is that a single child experiences several different kinds of seizure: tonic seizures, in which the body stiffens, often during sleep; atonic or “drop” seizures, in which muscle tone vanishes suddenly and the child falls, sometimes injuriously; and atypical absence seizures, brief lapses of awareness. These seizures are frequent and notoriously resistant to medication. Alongside them, the syndrome is generally accompanied by intellectual disability and developmental delay, and most people with LGS need substantial lifelong support.</p>
<p>The condition can arise from many underlying causes, from brain injury and malformation to genetic factors, and in a significant proportion of cases no specific cause is ever identified. That uncertainty, combined with the difficulty of controlling the seizures, makes both diagnosis and treatment unusually complex, and it is much of the reason families navigating LGS face such a long and demanding road.</p>
<h2 id="a-history-written-across-two-countries">A history written across two countries</h2>
<p>The medical history of LGS reaches back further than its 1966 christening. In the late 1930s, the American researchers Frederic and Erna Gibbs identified on electroencephalography a distinctive “slow spike-and-wave” pattern, which they termed the “petit mal variant”. Shortly afterwards William Lennox, working in Boston, described children who combined that pattern with intellectual impairment and multiple seizure types. The picture was sharpened in France, where Henri Gastaut, director of a regional centre for children with epilepsy at the University of Marseille, organised his symposia to pin down the entity precisely.</p>
<p>The naming after both Lennox and Gastaut acknowledged this trans-Atlantic, decades-long collaboration. It is a useful reminder that the conditions we name in a single phrase are usually the product of many hands working in different places over a long time, and that the steady accumulation of careful observation is itself a kind of progress.</p>
<h2 id="the-foundation-behind-the-day">The foundation behind the day</h2><div class="ad-unit ad-in-article" aria-label="Advertisement">
<span class="ad-label">Advertisement</span>
<ins class="adsbygoogle" style="display:block;text-align:center"
data-ad-client="ca-pub-3726833845844946"
data-ad-slot="3291553914"
data-ad-format="auto"
data-full-width-responsive="true"></ins>
<script>(adsbygoogle = window.adsbygoogle || []).push({});</script>
</div>
<p>If the syndrome’s name comes from the clinic, the awareness day comes from a family. The day is the work of the LGS Foundation, an American non-profit founded by Christina SanInocencio, who grew up watching her older brother Michael live with the condition. Confronted by how little support and how few resources existed for families like hers, she built an organisation to connect those families, fund research and push the condition into public view. The foundation designated 1 November as the awareness day, placing it deliberately at the head of National Epilepsy Awareness Month in the United States, so that attention to one rare syndrome opens a wider month-long focus on epilepsy in all its forms.</p>
<p>That origin in lived experience gives the day a particular texture. It was not handed down by an institution but built upward by a sibling who refused to accept that a rare diagnosis should mean a lonely one.</p>
<h2 id="the-long-search-for-treatment">The long search for treatment</h2>
<p>Part of what an awareness day quietly marks is how far the medicine has come, and how far it still has to go. For much of the twentieth century, LGS was largely untreatable; the multiple seizure types meant that a drug calming one kind could worsen another, and “drop attacks” in particular resisted control. Over recent decades the picture has improved in fits and starts. Several anti-seizure medications, including rufinamide, clobazam and lamotrigine, have been licensed specifically to help manage LGS, though none offers a cure and all carry trade-offs.</p>
<p>Two developments are worth singling out. In the late 2010s a purified, pharmaceutical-grade cannabidiol (CBD) derived from the cannabis plant was approved in the United States and Europe for treating seizures in LGS, one of the first prescription cannabis-based medicines, after trials showed it reduced the frequency of drop seizures. Older approaches have also proved their worth: the ketogenic diet, a strict high-fat, low-carbohydrate regimen first developed for epilepsy in the 1920s, remains a genuine option for some children when drugs fail, and surgical techniques such as corpus callosotomy can reduce the most dangerous falls. None of this would attract research funding without sustained attention to the condition, which is precisely the practical work an awareness day does.</p>
<h2 id="why-it-matters">Why it matters</h2>
<p>Rarity is its own kind of obstacle. A condition that affects relatively few people attracts less research funding, fewer specialist clinicians and less public understanding than common diseases, even when its impact on each affected family is profound. An awareness day works against that imbalance: by sharing accurate information about the seizure types and the treatment options, it chips away at the stigma that still surrounds epilepsy and helps families recognise what they are dealing with sooner.</p>
<p>It also serves a concrete strategic purpose, drawing the attention of funders, researchers and drug developers toward a disorder they might otherwise overlook. That advocacy aligns LGS Awareness Day with the broader family of rare-condition observances, such as <a href="/specialdate/international-albinism-awareness-day/">International Albinism Awareness Day</a> and <a href="/specialdate/moebius-syndrome-awareness-day/">Moebius Syndrome Awareness Day</a>, each of which fights the same battle against invisibility on behalf of a small population with outsized needs.</p>
<h2 id="living-with-lgs-day-to-day">Living with LGS day to day</h2>
<p>Behind the clinical description lies a reality that statistics rarely convey. For a family, LGS often means a household reorganised around seizures: protective headgear to guard against the injuries of drop attacks, a regimen of several medications taken on a strict schedule, broken sleep, frequent hospital visits and the constant low hum of vigilance. As children with LGS grow into adults, who in many cases continue to need substantial care, the questions shift to housing, guardianship and what happens when ageing parents can no longer provide the support themselves. These are not problems a single awareness day can solve, but visibility changes the context in which families fight for them, from school provision and disability funding to access to specialist clinics. Naming the condition publicly is the first step toward treating its everyday burdens as a shared responsibility rather than a private misfortune.</p>
<h2 id="how-it-is-marked">How it is marked</h2>
<p>On 1 November, advocacy organisations, hospitals and support groups run awareness campaigns, fundraising drives, webinars and educational sessions. Landmarks are sometimes illuminated in symbolic colours, and families share their own stories online to put a human face to a clinical label. Clinicians use the occasion to highlight advances in diagnosis and treatment, and much of the money raised flows directly into research and into the family-support programmes that the day’s community depends on.</p>
<h2 id="symbols-and-variations">Symbols and variations</h2>
<p>As with epilepsy awareness more broadly, the colour purple recurs through LGS campaigns, on ribbons, lighting and clothing. Beyond that, the day’s defining medium is personal storytelling: the testimony of parents, siblings and carers, which conveys what no statistic can. Because the LGS Foundation is rooted in the United States, the most organised activity tends to cluster there, but participation has spread to clinicians, organisations and families in many other countries, each adapting the day to their own health systems and support networks.</p>
<h2 id="fun-facts">Fun facts</h2>
<ul>
<li>The syndrome’s name honours two researchers, the American William Lennox and the French Henri Gastaut, who described it independently on different continents before their work was joined together.</li>
<li>It was William Lennox’s own daughter, the neurologist Margaret Lennox-Buchthal, who proposed naming the syndrome partly after her father at the 1966 Marseille meeting.</li>
<li>The characteristic “slow spike-and-wave” brain-wave pattern central to diagnosing LGS was first identified by the Gibbs husband-and-wife research team in the late 1930s, years before the syndrome was formally named.</li>
<li>The LGS Foundation was started by a sister, Christina SanInocencio, on behalf of her brother Michael, making the awareness day an unusually direct product of one family’s experience.</li>
</ul>
<h2 id="a-closing-reflection">A closing reflection</h2>
<p>There is a quiet symmetry in this day. The syndrome itself was assembled over decades by strangers in different countries who kept comparing notes until a coherent picture emerged, and the awareness day was assembled by a family that kept reaching out until a scattered community could find one another. Both are acts of connection performed against difficulty, the patient stitching together of isolated observations and isolated lives into something that holds. For a condition defined partly by how alone it can make people feel, that may be the most fitting tribute of all.</p>
Advertisement
Related Content
Advertisement
